kearny
Anupam Dalal, M.D.

dalalAnupam is a general partner at KVP, having joined after five years with Flagship Ventures.

Anupam is a board member of Akebia Therapeutics. At Flagship, he was a board member with Resolvyx Pharmaceuticals and Pervasis and an observer at CGI Pharmaceuticals, Adnexus Therapeutics (acquired by Bristol-Myers Squibb) and Acceleron Pharma.

Prior to Flagship Ventures, Anupam received his M.D. from the University of California, San Francisco, with honors. Anupam was Resident in Surgery at Brigham and Women's Hospital / Harvard Medical School. He received an MBA from Harvard Business School, with Distinction, and a BA (Phi Beta Kappa) in Economics summa cum laude from the University of California at Berkeley.

Contact Anupam at anupam@kearnyvp.com.